Sort
15,842 grants matching “pancreatic cancer”
Ras, Cycling and Inhibition.
$232,711Nicolas Nassar · State University New York Stony Brook · R01 · FY2007 · CA
Ras, Cycling and Inhibition.
$232,711Nicolas Nassar · State University New York Stony Brook · R01 · FY2008 · CA
Ras, Cycling and Inhibition.
$232,711Nicolas Nassar · State University New York Stony Brook · R01 · FY2009 · CA
Minimally invasive ablative therapies for pancreatic cystic neoplasms
$232,641Carlos Cuevas · University Of Washington · R21 · FY2013 · CA
Chemoprevention of Pancreatic Cancer by EGCG
$232,614Rakesh K. Srivastava · University Of Kansas Medical Center · R01 · FY2009 · CA
Mechanisms of ceftazidime-avibactam susceptibility and resistance among Enterobacteriaceae expressing variant KPCs
$232,558Cornelius J Clancy · University Of Pittsburgh At Pittsburgh · R21 · FY2019 · AI
Needle biopsy preservation and preparation for rapid 3D pathology of pancreas
$232,550Eric J Seibel · University Of Washington · R21 · FY2014 · CA
EORTC HEADQUARTERS
$232,518Denis Lacombe · European Org/Res/Treatment/Cancer · U10 · FY2011 · CA
VTCN1 regulation of MHC in early human placental development
$232,500Danny J Schust · University Of Missouri-Columbia · R21 · FY2020 · AI
"Mechanisms of Damage-Induced Homologous Recombination"
$232,412Bevin P. Engelward · Massachusetts Institute Of Technology · R01 · FY2011 · CA
PANCREAS CANCER MESOTHELIN ANIMAL MODEL
$232,231Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2008 · CA
Prediction and assessment of response to targated therapy in pancreatic cancer
$232,229Soner Altiok · Johns Hopkins University · R21 · FY2006 · CA
ANTITUMOR IMMUNITY INDUCED BY FUSION CELLS VACCINATION
$232,200Dana-Farber Cancer Institute · R01 · FY2000 · CA
CORE--TISSUE RESEARCH AND PATHOLGOGY SERVICES
$232,136Rajiv Dhir · University Of Pittsburgh At Pittsburgh · P30 · FY2007 · CA
FUNCTIONAL GENOMICS OF THE DEVELOPING ENDOCRINE PANCREAS
$232,100Washington University · R24 · FY2001 · DK
Core B: Preclinical Therapeutics Core
$232,061Cyril Henri Benes · University Of Tx Md Anderson Can Ctr · P01 · FY2020 · CA
EVALUATE LAG3 AND OTHER IMMUNE MODULATORS
$232,011Drew M. Pardoll · Johns Hopkins University · U19 · FY2008 · CA
ERK inhibitor resistance and ERK isoform-dependent growth in pancreatic cancer
$231,887Channing J Der · Univ Of North Carolina Chapel Hill · R21 · FY2014 · CA
Lung fibrosis impairs tumor immunity and limits immune checkpoint efficacy
$231,870Brett Howard Herzog · Washington University · K08 · FY2024 · CA
Lung fibrosis impairs tumor immunity and limits immune checkpoint efficacy
$231,870Brett Howard Herzog · Washington University · K08 · FY2025 · CA
Characterization of Cancer Transcriptomes using Next Generation Sequencing
$231,830Christopher A Maher · Washington University · R00 · FY2012 · CA
Innate Immune Mechanisms Contributing to Cancer Growth in Obesity
$231,825Edgar G. Engleman · Stanford University · R01 · FY2023 · CA
Genomics Core Facility
$231,806Michael D Topal · Univ Of North Carolina Chapel Hill · P30 · FY2013 · CA
Genetic Dissection of Stress Responses in Shwachman-Diamond Syndrome
$231,801Seth Joel Corey · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · DK
Determination of solution structures by NMR
$231,750David A Case · Rutgers, The State Univ Of N.J. · R01 · FY2009 · GM